Unlocking innovation in cancer care: A call to action for system-level change (AstraZeneca sponsored)
At a recent AstraZeneca UK sponsored HSJ roundtable event for NHS stakeholders, I had the privilege of hearing directly from clinicians, digital leads, and operational decision-makers across multiple cancer pathways.
Powering progress through standards: reflections from the GS1 UK Healthcare Conference 2025
The 2025 GS1 UK Healthcare Conference brought together senior NHS leaders, clinicians and policymakers at a pivotal moment for the health service
Resetting the standard: How 18 Week Support is evolving to help NHS trusts meet RTT and cost pressures
18 Week Support explains why it has restructured to become more agile, responsive, and cost-effective – and ultimately better able to support the NHS in meeting its targets
Making the most of the NHS estate
The NHS continues to face significant financial pressures. With integrated care boards recently tasked with cutting running costs by 50 per cent, there’s an urgent need to rethink how we deliver excellent patient care while reducing expenditure.
From healthcare assistant to registered practitioner: career ladders that work
With budget cuts biting and recruitment challenges mounting, NHS trusts are under pressure to do more with less. But what if the answer to futureproofing your workforce lies not in external hires, but in the talented, committed people already within your organisation?
The digital shift in mental health: What NHS leaders need to know
Decisions in healthcare are never simple, especially in mental health hospitals where patient needs are nuanced and care environments are complex.
Cardiovascular health – the key to better cancer outcomes
Accord shares how cardiovascular risk impacts long-term patient outcomes in cancer care and how many survivors are at an increased risk of CVD due to the treatments themselves
Beyond the buzzwords: Realising tangible ROI from digital, data and AI upskilling in the NHS
In his review of the state of the NHS, Lord Darzi commented that the health service is in the “foothills of digital transformation” – with an opportunity ahead to unlock productivity and deliver better care with technology.
Tackling the systemic and economic burden of multiple myeloma in England
Multiple myeloma accounts for 15 per cent of all blood cancers and in recent years, its prevalence has risen sharply and is set to continue to increase by 67 per cent over the next 20 years.1,2